Terms: = Skin cancer AND MDM4, DKFZp781B1423, 4194, ENSG00000198625, RP11-430C7_1, MRP1, MDMX, MGC132766 AND Treatment
22849 results:
1. LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa.
De Felice B; De Luca P; Montanino C; Mallardo M; Babino G; Mattera E; Sorbo R; Ragozzino G; Argenziano G; Daniele A; Nigro E
Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38757342
[TBL] [Abstract] [Full Text] [Related]
2. Navigating diagnostic challenges-distinguishing malignant melanoma and clear cell sarcoma of soft tissues: a case report and review of the literature.
Abdouh S; Boujguenna I; Soleh A; Abkari I; Rais H
J Med Case Rep; 2024 May; 18(1):249. PubMed ID: 38755643
[TBL] [Abstract] [Full Text] [Related]
3. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
[TBL] [Abstract] [Full Text] [Related]
4. Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients.
Song H; Hu Z; Zhang S; Yang L; Feng J; Lu L; Liu Y; Wang T
J Dermatolog Treat; 2024 Dec; 35(1):2350231. PubMed ID: 38754985
[No Abstract] [Full Text] [Related]
5. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.
Bang AS; Said JT; Hirner J; Rana J; Pugliese S; Wang JY; Zaba L; Zhao L; Doan L; Smith J; Kwong BY
Support Care Cancer; 2024 May; 32(6):354. PubMed ID: 38750379
[TBL] [Abstract] [Full Text] [Related]
6. Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
Gogineni E; Chen H; Hu C; Boudadi K; Engle J; Levine A; Deville C
Radiat Oncol; 2024 May; 19(1):56. PubMed ID: 38745333
[TBL] [Abstract] [Full Text] [Related]
7. Hospitalization and mortality in Asian autoimmune bullous dermatosis patients: A 17-year retrospective study.
Amonchaisakda N; Rujitharanawong C; Tuchinda P; Kulthanan K; Chularojanamontri L
Exp Dermatol; 2024 May; 33(5):e15095. PubMed ID: 38742822
[TBL] [Abstract] [Full Text] [Related]
8. Phytochemical study of
Moraes ARA; Siqueira EP; Kohlhoff M; Evangelista FCG; Sabino AP; Vieira Filho SA; Alcântara AFC; Duarte LP; Sousa GF
Nat Prod Res; 2024 Jun; 38(11):1956-1960. PubMed ID: 38739565
[No Abstract] [Full Text] [Related]
9. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
Stoyukhina AS
Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
[TBL] [Abstract] [Full Text] [Related]
10. Based on Immune Microenvironment and Genomic Status, Exploring Immunotherapy in Advanced Hidradenocarcinoma: A Retrospective Analysis.
Lin J; Zhu L; Chen Y; Li Q; Ke Z; Zhang H; Huang Y; Lu J; Chen Y
Acta Derm Venereol; 2024 May; 104():adv22146. PubMed ID: 38738772
[TBL] [Abstract] [Full Text] [Related]
11. A dosiomics model for prediction of radiation-induced acute skin toxicity in breast cancer patients: machine learning-based study for a closed bore linac.
Saadatmand P; Mahdavi SR; Nikoofar A; Jazaeri SZ; Ramandi FL; Esmaili G; Vejdani S
Eur J Med Res; 2024 May; 29(1):282. PubMed ID: 38735974
[TBL] [Abstract] [Full Text] [Related]
12. Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study.
Mordoh J; Schwab E; Bravo AI; Aris M; Barrio MM
Front Immunol; 2024; 15():1354710. PubMed ID: 38726010
[TBL] [Abstract] [Full Text] [Related]
13. Monitoring Adolescent and Young Adult Patients With cancer via a Smart T-Shirt: Prospective, Single-Cohort, Mixed Methods Feasibility Study (OncoSmartShirt Study).
Steen-Olsen EB; Pappot H; Hjerming M; Hanghoej S; Holländer-Mieritz C
JMIR Mhealth Uhealth; 2024 May; 12():e50620. PubMed ID: 38717366
[TBL] [Abstract] [Full Text] [Related]
14. Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
Moser JC; Bhatia S; Amin A; Pavlick AC; Betts KA; Du EX; Poretta T; Shelley K; Srinivasan S; Sakkal LA; Palaia J; Lobo M; Pe Benito M; Linton JA; Chen Y; Xu C; Yin L; Sundar M; Weber J
Cancer Immunol Immunother; 2024 May; 73(7):116. PubMed ID: 38713408
[TBL] [Abstract] [Full Text] [Related]
15. Long-term survival after anti-PD-1 discontinuation in advanced cutaneous squamous cell carcinoma (cSCC): a proof of concept of benefit of concomitant cemiplimab and radiotherapy.
Bailly-Caillé B; Levard R; Kottler D; Dompmartin A; L'Orphelin JM
Cancer Immunol Immunother; 2024 May; 73(7):118. PubMed ID: 38713217
[TBL] [Abstract] [Full Text] [Related]
16. Beyond the Label: Real-World Side Effects Experienced With FDA-Approved Drugs for Non-Melanoma skin cancers.
Ravipati A; Pradeep T; Nouri K
J Drugs Dermatol; 2024 May; 23(5):301-305. PubMed ID: 38709693
[TBL] [Abstract] [Full Text] [Related]
17. Patient reported outcomes and patient experiences of immune checkpoint modulators for advanced or recurrent melanoma: a mixed methods study.
Tometich DB; Geiss C; Maconi ML; Chavez M; Hoogland AI; Li X; Nieves-Lopez A; Rodriguez Y; Bryant C; Brohl AS; Eroglu Z; Markowitz J; Tarhini AA; Hwu P; Khushalani NI; Jim HSL
Support Care Cancer; 2024 May; 32(6):330. PubMed ID: 38709312
[TBL] [Abstract] [Full Text] [Related]
18. Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study.
Ding W; Chen L; Xia J; Pei B; Song B; Li X
Medicine (Baltimore); 2024 May; 103(18):e38010. PubMed ID: 38701318
[TBL] [Abstract] [Full Text] [Related]
19. Response of treatment-naive brain metastases to stereotactic radiosurgery.
Ene CI; Abi Faraj C; Beckham TH; Weinberg JS; Andersen CR; Haider AS; Rao G; Ferguson SD; Alvarez-Brenkenridge CA; Kim BYS; Heimberger AB; McCutcheon IE; Prabhu SS; Wang CM; Ghia AJ; McGovern SL; Chung C; McAleer MF; Tom MC; Perni S; Swanson TA; Yeboa DN; Briere TM; Huse JT; Fuller GN; Lang FF; Li J; Suki D; Sawaya RE
Nat Commun; 2024 May; 15(1):3728. PubMed ID: 38697991
[TBL] [Abstract] [Full Text] [Related]
20. MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use.
Syc-Mazurek SB; Zhao-Fleming H; Guo Y; Tisavipat N; Chen JJ; Zekeridou A; Kournoutas I; Orme JJ; Block MS; Lucchinetti CF; Mustafa R; Flanagan EP
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200249. PubMed ID: 38696737
[TBL] [Abstract] [Full Text] [Related]
[Next]